Background-Disease entities such as diabetes, neurodegeneration and cardiovascular disorders affect a significant portion of the world's population.
Introduction
In multiple disorders, cellular survival and cellular longevity are intimately dependent upon exposure to oxidative stress, the induction of apoptotic pathways and immune system function. Oxidative stress occurs as a result of the development of reactive oxygen species (ROS) that consist of oxygen free radicals and additional chemical entities. Oxygen free radicals and mitochondrial DNA mutations have become associated with tissue injury, aging, and accumulated toxicity for an organism [1] . ROS include superoxide free radicals, hydrogen peroxide, singlet oxygen, nitric oxide, and peroxynitrite [2] . Most species are produced at low levels under normal physiological conditions and are scavenged by endogenous antioxidant systems that include superoxide dismutase, glutathione peroxidase, catalase and small †Wayne State University School of Medicine, Department of Neurology, 8C-1 UHC, 4201 Street, Antoine, Detroit, MI 48201, USA, Tel: +1 313 966 0833;, Fax: +1 313 966 0486;, E-mail: kmaiese@med.wayne.edu, aa2088@wayne.edu. Declaration of interest The authors declare no conflicts of interest and have received no payment for preparation of this manuscript. molecule substances such as vitamins C and E and nicotinamide, the amide form of niacin or vitamin B 3 [3] [4] [5] .
Yet, under conditions which fail to adequately control ROS in biological systems, oxidativestress-induced apoptotic cell injury can contribute to a variety of disease states such as diabetes, stroke, neurodegeneration, and trauma [1, 6] . More importantly, it has been shown recently that genes involved in the apoptotic process are replicated early during processes that involve cell replication and transcription, suggesting a much broader role for these genes than originally anticipated [7] . As a result, oxidative stress leads to apoptosis in multiple cell types that include neurons, cardiomyocytes, endothelial cells and smooth muscle cells.
Interestingly, the ability to modulate inflammatory cell activity can ultimately affect cell survival and longevity since activated immune cells can lead to the phagocytic removal of both neurons and vascular cells. Inflammatory cells, such as microglia, require the activation of intracellular cytoprotective pathways to proliferate and remove injured cells [8, 9] . Subsequently, microglia can form a barrier for the removal of foreign microorganisms from the central nervous system and promote tissue repair during neuronal and vascular cell injury [10] . Yet, microglia also may lead to cellular damage through the generation of ROS and through the production of cytokines [9] . In fact, inflammatory cell activation has been associated with several neurodegenerative disorders, such as Alzheimer's disease, with the colocalization of microglia and amyloid plaque development [1, 6] .
Given the intricate relationships that govern cellular survival, longevity and inflammation during oxidative stress, the successful development of novel therapeutic strategies for multiple disease entities can rest heavily upon the ability to balance each of these parameters. In this regard, future investigations must overcome the present challenges of existing therapies and identify new cellular pathways that foster cellular longevity but do not lead to clinical demise through detrimental effects such as tumorigenesis. Here we discuss the potential of two unique signaling pathways, namely Wnt and mammalian forkhead transcription factors predominantly of the O class superfamily, which have become increasingly recognized for their involvement not only in oxidative stress and cellular survival but also for their ability to significantly affect immune system function and cancer.
Wnt signaling pathways
Wnt proteins, derived from the Drosophila Wingless (Wg) and the mouse Int-1 genes, are secreted cysteine-rich glycosylated proteins that can control cell proliferation, differentiation, survival and tumorigenesis [11] [12] [13] [14] . More than 80 target genes of Wnt signaling pathways have been demonstrated in human, mouse, Drosophila, Xenopus and zebrafish. These genes are present in several cellular populations, such as neurons, cardiomyocytes, endothelial cells, cancer cells and preadipocytes. At least 19 of 24 Wnt genes that express Wnt proteins have been identified in humans [12, 15] .
Wnt proteins are generally divided into functional classes based on their ability to induce a secondary body axis in Xenopus embryos and to activate certain signaling cascades that consist of the Wnt1 class and the Wnt5a class. These involve intracellular signaling pathways that are critical for Wnt signal transduction. One of the Wnt pathways controls target gene transcription through β-catenin, generally referred to as the canonical pathway that involves Wnt1, Wnt3a and Wnt8 (Figure 1 ). Other Wnt pathways pertain to intracellular calcium release (Figure 1 ). These involve the non-canonical or Wnt/calcium pathway consisting primarily of Wnt4, Wnt5a and Wnt11 that function through non-β-catenin-dependent pathways and also include the planar cell polarity (PCP) pathway or the Wnt-calcium-dependent pathways [12, 15] . However, it should be stated that the lines between these pathways are sometimes blurred and not distinct, especially with the reliance upon common pathways that can involve calcium signaling and Dishevelled (DVL), a cytoplasmic multifunctional phosphoprotein. Furthermore, noncanonical pathways, such as Wnt5a, may antagonize canonical pathways by leading to the degradation of β-catenin [16] .
Wnt signaling, development, and stem cells
Wnt signaling pathways are initiated by interaction of Wnt proteins with Frizzled (FZD) receptors and the binding of the Wnt protein to the FZD transmembrane receptor in the presence of the co-receptor low density lipoprotein receptor-related protein (LRP)-5/6 [12, 14, 15] . Once the Wnt protein binds to the FZD transmembrane receptor and the co-receptor LRP-5/6, this is followed by recruitment of DVL. The Wnt-Frizzled transduction pathway plays a significant role in the control of the pattern of the body axis as well as the development and maturation of the central nervous system, cardiovascular system, and the limbs [12, 14, 15] . For example, through β-catenin and glycogen synthase kinase-3β (GSK-3β), Wnt signaling can control hippocampal and subventricular zone progenitor cell proliferation and differentiation [17, 18] . In addition, modulation of β-catenin [19] or GSK-3β [20] in the Wnt pathway may be involved in the development and maintenance of midbrain dopaminergic neurons. In mature organisms, the Wnt pathway can respond to injury through neural stem cell proliferation [12] .
In the cardiac and vascular systems, Wnt signaling has been shown to mediate the development of early blood and endothelial cells from human embryonic stem cells [21] . Activation of the Wnt pathway promotes multipotential mesendodermal progenitor cells to differentiate along endothelial, cardiac and vascular smooth muscle lineages [22] . In addition, canonical Wnt signaling fosters the expression of mammalian cardiac progenitors [23] as well as right ventricular growth [24] . Other work that has generated conditional β-catenin-deletion mutant animals in the proepicardium demonstrated that the epicardial β-catenin pathway is required for the development of the subepicardial space and the differentiation of epicardium-derived mesenchymal cells into coronary smooth muscle cells [25] . Interestingly, the temporal sequence of events can determine the course of differentiation of stem cells. Activation of the Wnt/β-catenin pathway in the early phase during embryoid body formation enhances embryonic stem cell differentiation into cardiomyocytes but activation of this pathway in the late phase after embryoid body formation inhibits cardiomyocyte differentiation and enhances the expression of hematopoietic/vascular marker genes [26] .
Wnt signaling, cell metabolism, injury, and immune system regulation
A number of studies also suggest the robust potential of Wnt to not only promote cellular development but also to limit cell injury in several disease entities associated with apoptosis. Recent studies suggest that the Wnt pathway plays a significant role in disorders such as diabetes mellitus (DM). DM affects approximately 16 million individuals in the United States and more than 165 million individuals worldwide [27, 28] . Dysfunctional Wnt signaling, as with transcription factor 7-like 2 gene, may impart increased risk for type 2 DM in some populations [29] as well as having increased association with obesity [30] . Clinical observations in patients with coronary artery disease and the combined metabolic syndrome with hypertension, hyperlipidemia, and DM have observed impaired Wnt signaling through a missense mutation in LRP-6 [31] .
These clinical observations for Wnt in conditions associated with hyperglycemia and DM suggest a potential cytoprotective role for the Wnt pathway. Experimental studies in mice that develop hyperglycemia through a high-fat diet demonstrate increased expression of some Wnt family members, such as Wnt3a and Wnt7a [32] . Yet, intact Wnt family members may confer glucose tolerance and increased insulin sensitivity as well as protecingt glomerular mesangial cells from elevated glucose-induced apoptosis [12] . Animals that overexpressed Wnt10b and were placed on a high-fat diet had a reduction in body weight, hyperinsulinemia and triglyceride plasma levels and improved glucose homeostasis [33] . In cell culture studies, administration of Wnt1 protein can significantly prevent apoptosis in endothelial cells (ECs) during elevated glucose exposure and protection is controlled by the growth factor erythropoietin (EPO) [34] that can modulate vascular stability [35] . Clinical applications for EPO and the Wnt signaling pathway of GSK-3β also may be potentially attractive [2, [36] [37] [38] . For example, both the benefits of EPO to improve cardiovascular function in diabetic patients and the positive effects of exercise to improve glycemic control during DM appear to rely upon the inhibition of GSK-3β activity. EPO blocks GSK-3β activity [9, 34, 39] and combined with exercise may offer synergistic benefits, since physical exercise also has been shown to phosphorylate GSK-3β and inhibit its activity [40] .
The Wnt pathway also has a significant role during degenerative disease in the nervous and vascular systems. For example, although it is unclear whether Wnt directly plays in the development of neuropsychiatric or dementia disorders, the Wnt pathway has been tied to several pathological components that can result in cognitive impairment. Experimental models of behavior suggest that the ability to tolerate stressful environments and models of social defeat may be associated with the expression of Wnt2 [12] . The Wnt pathway also has been demonstrated in the brains of individuals affected by neuropsychiatric disorders [12, 15] . In models of frontotemporal dementia, components of Wnt signaling can be upregulated during the initial onset of disability [41] . Genetic analysis also suggests that LRP-6 variants of the Wnt pathway may be associated with late onset alzheimer's disease and that upregulation of the Wnt pathway may provide alternative treatments for this condition [12] . Since β-amyloid is considered a principal target for the treatment of Alzheimer's disease [42] , other work has examined the ability of Wnt to directly reduce β-amyloid toxicity. Recent investigations suggest that the potential of statins, such as lovastatin, to reduce the prevalence of Alzheimer's disease are a result of a decrease in β-amyloid production that involves the Wnt signaling pathways of β-catenin and GSK-3β [43] . In addition, cell culture studies appear to further support these observations by demonstrating that Wnt1 is a necessary component to prevent neuronal injury during β-amyloid exposure [44] . In particular, Wnt1 relies upon the activation of protein kinase B (Akt) that may be protective in animal models of dementia [45] as well as the inhibition of GSK-3β with the cellular translocation β-catenin to the nucleus [44] .
In relation to vascular development and injury, Wnt can foster angiogenesis and cytoprotection of ECs. Several Wnt ligands, such as Wnt2, Wnt5a, Wnt7a and Wnt10b, are expressed endogenously in ECs and vascular smooth muscle cells. Antagonism of the Wnt system can block endothelial cell proliferation [12, 15] . Studies with mice homozygous for the deletion of the Wnt receptor ligand Fzd5 that can synergize with Wnt2, Wnt5a and Wnt10b have been shown to produce embryos that die in utero approximately 10 days post coitum as a result of defects in yolk sac angiogenesis, supporting a critical role for Wnt during embryonic vascular development [46] . In contrast, heterozygous mice were found to be viable and fertile and appeared normal. In addition, FrzA, as a member of secreted FZD-related protein, can increase migration and tube formation of ECs to result in enlargement, elongation, and maturation of vessels, further supporting the requirement for the Wnt-FZD signaling pathway during development and maturation of blood vessels [47] . Wnt family members, through canonical pathways, have been shown to be important for the development of human embryonic stem cells with hematopoietic and endothelial potential [21] . Furthermore, non-canonical pathways that involve Wnt5a may be necessary for EC growth and angiogenesis [48] .
In the light of the significant role that inflammatory cells may play during oxidative stress and cell injury, it has become essential to understand the role of Wnt during inflammatory cell activation. Wnt transcripts, such as Wnt 4, 7b, 10b and 13, can be upregulated in macrophages during human colorectal cancer [12, 15] . Other work has suggested that Wnt family members, such as Wnt7b in macrophages, may be responsible for the apoptotic cell death of adjacent vascular cells [49] and that inflammatory cells require components of the Wnt signaling pathway to maintain cellular integrity [8] . Interestingly, the canonical Wnt pathway can increase monocyte adhesion to ECs [50] and control transendothleial migration of monocytes [51] . Wnt1 has recently been shown to possess a unique capacity to not only prevent early apoptotic membrane phosphatidylserine exposure but also to directly modulate inflammatory microglial activation and proliferation that can lead to cellular engulfment and removal [44] .
FoxO transcription factors
Over 100 forkhead genes and 19 human subgroups, FOXA to FOXS, have been shown to exist since the initial discovery of the fly Drosophila melanogaster gene forkhead [1, 52] . In relation to the nomenclature for human Fox proteins, all letters are capitalized, only the initial letter is uppercase for the mouse, and for all other chordates the initial and subclass letters are in uppercase. Of the mammalian forkhead transcription factors in the O class, FoxO1, FoxO3, FoxO4 and FoxO6 exemplify the ability to function as versatile components during normal physiology as well as during progressive disease [53] . FOXO6 is the most recently cloned FoxO family member with expression demonstrated in the mouse brain. Study of FoxO1, FoxO3 and FoxO4 has revealed that these proteins are involved in processes ranging from cell death to cell longevity. Interestingly, FoxO proteins are homologous to the transcription factor Dauer formation-16 (DAF-16) in the worm Caenorhabditis elgans that can determine metabolic insulin signaling and lead to lifespan extension [52, 54] . Subsequent studies have shown that metabolic signaling with FoxO proteins is conserved among multiple species including C. elgans, D. melanogaster and mammals, suggesting the broad effect FoxO proteins may have upon mammalian cell function.
FoxO transcription factors and cell development
FoxO proteins are involved in the maintenance of erythroid, neuronal, and hematopoietic stem cells (Figure 2 ). On the surface, Foxo3a −/− and Foxo4 −/− mice develop without incident and are largely indistinguishable from control littermates, with similar weight gain [53] . However, mice singly deficient in Foxo1 die by embryonic day 10 or 11 and lack vascular system development [55] . In addition, Foxo3a −/− null mice become infertile and experience follicular activation to the extent that ovarian follicles are depleted by the subsequent death of oocytes, suggesting a specific role for Foxo3a in relation to oocyte and follicular development. Simultaneous deletion of Foxo1, Foxo3a and Foxo4 in mice also leads to the defective repopulation of hematopoietic stem cells with resultant apoptosis [56] . Other studies suggest that Foxo3a alone may play a role in maintaining hematopoietic stem cells, since these cells are significantly decreased in aged Foxo3 −/− mice compared with their littermate controls [57] . A number of cellular factors may determine whether FoxO proteins function in concert or independently to control progenitor cell growth. For example, the ability of EPO to foster eythroid progenitor cell development is dependent upon the inhibition of FoxO3a activity [37, 52] but also may require regulation of specific gene expression through an EPO-FoxO3a association to promote erythropoiesis in cultured cells [58] . In addition, rat enteric nervous system precursor development that occurs in the presence of the growth factor glia-cell-linederived neurotrophic factor appears to require the inactivation of FoxO1 and FoxO3a [59] .
FoxO transcription factors, cell metabolism, longevity and immune system function
FoxO proteins are involved in several pathways responsible for cell metabolism and DM. In a clinical study of 734 individuals, the c.-343 -1582 C > T polymorphism of FOXO3a displayed a significant association with body mass index such that the highest body mass index was present in individuals homozygous for this allele [60] . Analysis of the effects of genetic variation in FOXO1a and FOXO3a on metabolic profiles, age-related diseases, fertility, fecundity, and mortality have observed higher hemoglobin A 1c (HbA 1c ) levels and increased mortality risk associated with specific haplotypes of FOXO1a. In addition, there was an increased risk of stroke in two haplotypes of FOXO3a block-A, suggesting an association with cerebral oxidative stress disorders such as diabetes and stroke with FOXO1a and FOXO3a [61] . Experimental investigations have suggested that FoxO3a activation may be beneficial during elevated glucose exposure and DM. IFN-γ driven expression of tryptophan catabolism by cytotoxic T lymphocyte antigen 4 may activate Foxo3a to protect dendritic cells from injury in nonobese diabetic mice [62] . Yet, the role of forkhead transcription factors can vary among different cell types and tissues. For example, additional investigations have associated diabetic nephropathy with post-translational changes in FoxO3a by demonstrating that phosphorylation of FoxO3a increases in rat and mouse renal cortical tissues two weeks after the induction of diabetes by streptozotocin [37, 52] . Furthermore, enteric neurons can be protected from hyperglycemia by glia-cell-line-derived neurotrophic factor that can affect Akt signaling and prevent FoxO3a activation [37, 52] .
One potential agent to consider for the maintenance of cellular metabolism in DM that involves forkhead transcription factors is nicotinamide, a precursor for the coenzyme β-nicotinamide adenine dinucleotide (NAD + ). In patients with DM, oral nicotinamide protects β-cell function, prevents clinical disease in islet-cell antibody-positive first-degree relatives of type-1 DM, and can reduce HbA 1c levels [5, 27, 28] . Given the potential treatment advantages of nicotinamide in DM, it should be of interest to note that nicotinamide may derive its protective capacity through two separate mechanisms of post-translational modification of FoxO3a. Nicotinamide not only can maintain phosphorylation of FoxO3a and inhibit its activity but can also preserve the integrity of the FoxO3a protein, blocking FoxO3a proteolysis that can yield pro-apoptotic amino-terminal fragments [63] .
FoxO proteins also interface with several pathways including the Wnt signaling pathways that regulate cellular apoptosis and longevity during periods of oxidative stress and neurodegeneration ( Figure 2 ). In some cellular populations, such as mouse hematopoietic stem cells, the conditional deletion of FoxO1, FoxO3a and FoxO4 can lead to an increase in ROS [56] . However, it appears that FoxO proteins, such as FoxO1 and FoxO3a, must be present for oxidative stress to result in apoptotic cell injury [64] . With respect to chronic neurodegenerative disorders such as Alzheimer's disease, amyloid is toxic in cell culture [44, 65] and is associated with the phosphorylation of FoxO1 and FoxO3a that can be blocked with ROS scavengers [37, 52] . Interestingly, a common denominator in the pathways linked to amyloid toxicity involves Wnt signaling through β-catenin. β-catenin has been demonstrated to be necessary for protection against amyloid toxicity in neuronal cells [44] . However, during oxidative stress, β-catenin also may stimulate FoxO transcription and antagonize Wnt signaling pathways [66] . These observations correlate well with other cell culture and animal studies of oxidative stress demonstrating that protein inhibition or gene knockdown of FoxO1 or FoxO3a results in stroke reduction by estradiol [67] , mediates the protective effects of metabotropic glutamate receptors [68] , enhances neuronal survival through NAD + precursors [63] , and provides tropic factor protection with EPO [69] and neurotrophins [70] .
As an extension of the studies examining apoptotic cell injury, FoxO proteins also have been tied to cell longevity and ageing as demonstrated by early studies linking DAF-16 in C. elgans to increased longevity [37, 52] . In cultured human dermal fibroblasts, gene silencing of FoxO3a protein results in cell morphology consistent with senescence, increased cell population doubling times and the generation of ROS, suggesting that FoxO protein activity may be required to extend cell longevity [71] . Additional work in animal models of ageing demonstrates a reduction in sirtunin 1 (SIRT1) in the heart but no significant change in FoxO3a expression with advanced age. SIRT1 is a NAD + -dependent deacetylase and the mammalian ortholog of the silent information regulator 2 (Sir2) protein associated with increased lifespan in yeast. However, during exercise training, an upregulation of FoxO3a and SIRT1 activity is observed in the heart [72] , suggesting a broader effect of FoxO3a during processes that are associated with aging in the nervous and cardiovascular systems. In addition, FoxO proteins may be protective during aging, since loss of FoxO3a activity in explanted vascular smooth muscle of aged animals may limit tissue antioxidant properties through decreased manganesesuperoxide dismutase and lead to enhanced cell injury with ageing [37, 52] .
Given that inflammatory cell modulation has a significant effect upon cellular apoptosis, FoxO proteins also function as critical components for modulation of immune cell function ( Figure  2 ). Clinical studies have demonstrated the phosphorylation of FOXO1 in macrophages, FOXO3a in T lymphocytes and FOXO4 in macrophages in synovial biopsy tissue of patients with rheumatoid arthritis and osteoarthritis, suggesting that inhibitory post-translational phosphorylation of these FOXO family members leads to inflammatory cell activation [73] . Other clinical studies have shown that FOXO1 gene transcript levels were downregulated in peripheral blood mononuclear cell of patients with systemic lupus erythematosus and rheumatoid arthritis [74] , illustrating a potential etiology for these disorders and possibly providing a biomarker of disease activity. Clinical work also suggests a relationship between the regulation of immune system activity and the induction of apoptotic pathways that are dependent upon FoxO proteins. FoxO proteins may work in concert with Fas signaling to clear activated T cells following a decrease in cytokine stimulation in patients with autoimmune lymphoproliferative syndromes, suggesting that specific FoxO proteins are targeted for treatment of autoimmune disorders [75] .
In mice deficient for Foxo3a, lymphoproliferation, organ inflammation of the salivary glands, lung and kidney, and increased activity of helper T cells results, supporting an important role for FoxO3a in preventing T cell hyperactivity [52] . FoxO3a also appears to be necessary for neutrophil activity, since Foxo3a −/− null mice are resistant to models of neutrophilic inflammation that involve immune complex-mediated inflammatory arthritis and thioglycollate-induced peritonitis [52] . Prevention of inflammatory activation and apoptosis in the nervous system such as in systemic lupus erythematosus in animal models may require the upregulation of FoxJ1 and FoxO3a that can block NF-κB activation and IFN-γ secretion [76] . Furthermore, animal studies using experimental autoimmune encephalomyelitis to mimic multiple sclerosis and myelin injury have shown that osteopontin, a protein expressed in multiple sclerosis lesions, leads to the prolonged survival of myelin-reactive T cells and disease progression through a combination of events that involve FoxO3a inhibition, NF-κB activation, and the expression of the pro-apoptotic proteins bcl-2 interacting mediator of cell death (Bim), bcl-2 homologous antagonist/killer (Bak), and Bcl2-associated X protein (Bax) [77] .
Wnt, FoxO, common pathways, and cancer
Given the intimate links that are required among cellular signaling pathways and gene transcription, it comes as no surprise that Wnt and forkhead proteins can rely upon one another in a number of scenarios (Table 1) . For example, FoxD3 is activated by the Wnt pathway to control neural plate development [78] and FoxI1 activates the Wnt/β-catenin pathway to increase extracellular proteoglycans and promote gastrointestinal cell proliferation [79] . The Wnt pathway also utilizes forkhead members to modulate endocrine activity and can activate FoxN1 for regulatory control of thymic function [80] . In other examples of cell development, Wnt signaling has been shown to rely upon FoxF1 and FoxF2 during intestinal maturation in murine models [81] . FoxA2 also may be a significant component in early anterior-posterior axis polarization [82] . The β-catenin pathway also appears to tie FoxO proteins and Wnt signaling together. For example, in relation to Alzheimer's disease, amyloid is toxic in cell culture [44, 65] and is associated with the phosphorylation of FoxO1 and FoxO3a that can be blocked with ROS scavengers (Table 1) [83] . Interestingly, a common denominator in the pathways linked to amyloid toxicity involves Wnt signaling through β-catenin. β-catenin may increase FoxO transcriptional activity and competitively limit β-catenin interaction with members of the lymphoid enhancer factor/T cell factor family [84] and β-catenin also has been demonstrated to be necessary for protection against amyloid toxicity in neuronal cells [44] .
In addition, Wnt and FoxO proteins share several common signal transduction pathways, such as the serine-threonine kinase Akt that is a primary mediator of phosphorylation of FoxO1, FoxO3a and FoxO4 is and involved in pathways of cytoprotection. Under most circumstances, activation of Akt is cytoprotective, such as during β-amyloid toxicity [65] and oxidative stress [2, 85] . Cellular apoptosis can be prevented during the phosphorylation of FoxO proteins by Akt to sequester FoxO transcription factors in the cytoplasm by association with 14-3-3 proteins and prevent the transcription of pro-apoptotic target genes [37, 69] . The exception to this rule involves FoxO6, which resides in the nucleus of cells and is phosphorylated by Akt in the nucleus. In addition to β-catenin/T cell factor (Tcf) transcription mediated pathways of Wnt that can prevent cell injury, recent work also has linked Wnt cytoprotection to Akt. For example, neuronal cell differentiation that is dependent upon Wnt signaling and tropic factor induction is blocked during the repression of Akt activity and Wnt differentiation of cardiomyocytes does not proceed without Akt activation [12, 15] . Reduction in cardiac tissue injury through Wnt signaling and the benefits of cardiac ischemic preconditioning appear also to rely upon Akt activation [12, 15] . Furthermore, Wnt overexpression can independently increase the phosphorylation and activation of Akt to promote neuronal protection and control microglial activation [44] .
However, the common pathways shared between Wnt and forkhead proteins may also have another side that relates to tumorigenesis (Table 1) [11, 15] . With regards to Wnt, deregulation in the Wnt pathway that promotes activation of β-catenin has been associated with the proliferation of medulloblastoma tumors [13] . In addition, reduced expression of inhibitors of the Wnt pathway, such as axin, may foster lung cancer cell invasion [86] . Multiple other studies also point to the activation of the Wnt pathway during gastric cancer. For example, Wnt-5a expression has been correlated with advanced gastric cancer stages and a poor prognosis [87] while experimental activation of the β-catenin pathway leads to the development of gastric tumors [88] . Furthermore, loss of the forkhead member FoxL1, which can regulate the Wnt pathway and prevent β-catenin nuclear accumulation, is believed to be a significant etiology for gastrointestinal tumorigenesis [89] . In addition, colorectal tumor formation may require not only β-catenin activity but also Akt activation that requires crosstalk between FoxO and Wnt signaling pathways [90] .
The regulatory potential of forkhead transcription factors over the Wnt pathway and the proapoptotic effects of forkhead proteins make forkhead family members almost ideal therapeutic targets to control tumor growth (Figure 2 ). Early studies of breast cancer reported that FOXO3a was confined to the cytoplasm of human tumor cells, inactivated, and associated with a poor prognosis in breast cancer [52] , suggesting that FOXO3a subcellular localization and pathways that enhance its activity could be used not only as prognostic assays but also as therapeutic targets. In animal studies, somatic deletion in mice of Foxo1, Foxo3a and Foxo4 results in the growth of thymic lymphomas and hemangiomas, illustrating the potential of FoxO proteins to function as repressors of tumor growth [91] . Studies with breast cancer parallel this work and show that increased activity of FoxO3a in breast cancer cell lines [92] or in isolated human breast cancer cells can suppress breast cancer progression [93] . Suppression of FoxO3a activity can also result in enhanced prostate tumor cell growth [94] while agents that increase FoxO3a activity in both androgen sensitive and androgen insensitive prostate cell lines prevent prostate cancer cell progression [95] . However, it has been shown in prostate cell lines that FoxO3a is a positive regulator of androgen receptor expression and therefore may play a complex role in prostate cancer cell proliferation and growth inhibition [96] . In relation to other cancers such as ovarian, colonic and hematopoietic cancers, FoxO3a activation can inhibit cell cycle progression and block proliferation of tumor growth in colon carcinoma cell lines [97] . In support of the need for cell cycle regulation by FoxO proteins, loss of FoxO3a activity in association with c-myc, p27, and NF-κB can result in cell cycle induction and malignant transformation [98] . Several studies also suggest that the loss of FoxO3a activity may participate in oncogenic transformation in B-chronic lymphocytic leukemia, in the progression of chronic myelogenous leukemia cell lines, and in the transformation of cells into Kaposi's sarcoma [52] . As a result, triple mutant FoxO3a expression that cannot be inhibited in its activity through phosphorylation has been proposed as a potential therapeutic target against melanoma tumors [99] . Interestingly, loss of functional FoxO3a in human ovarian cancer cell lines can limit the sensitivity of ovarian cancer cells to chemotherapy such as cisplatin [100] , suggesting that FoxO proteins may be responsible for altered treatment outcomes in the presence of combined therapeutic approaches.
Expert opinion
In the light of the ability of both the Wnt pathway and FoxO transcription factors to regulate a wide range of cellular processes through independent as well as integrated pathways, it is exciting to consider the almost limitless potential of Wnt and FoxO proteins for the development of novel therapeutic strategies that may address multiple disorders (Box 1). For example, integration of the nervous and cardiovascular systems through Wnt occurs at several cellular levels that relate to oxidative stress, apoptotic injury and inflammatory cell activation, eliciting great enthusiasm for the development of treatment strategies that range from the repair of injured cardiac tissue to the restoration of cognitive loss. In a similar vein, the known mutations in FoxO proteins that exist in several disease entities may provide additional insights into the treatment of a broad range of disorders. Further analysis in larger populations of patients with premature ovarian failure combined with functional studies could increase our understanding of the role of FoxO proteins in disorders of human fertility. In relation to the immune system, recent work has suggested that FoxO proteins may function as biomarkers of disease activity and also offer a potential target for the treatment of autoimmune disorders. Furthermore, the ability of FoxO proteins to control cell cycle progression and promote apoptotic cell death suggests that FoxO transcription factors may be developed for new advances against tumorigenesis. How can immune system activity infl uence whether Wnt or FoxO proteins will be effi cacious against tumor proliferation or become a signifi cant factor for the development of chemotherapeutic drug insensitivity? Yet, simplistic strategies for new therapeutic treatments utilizing Wnt and FoxO signaling are not entirely 'made to order', since several considerations can influence whether application of these pathways ultimately leads to beneficial or detrimental biological outcomes. Deregulation of Wnt can activate proliferative pathways such as Akt and β-catenin and lead to uncontrolled cellular proliferation and tumor growth that can involve the central nervous system, pulmonary system and gastrointestinal tract. On the other hand, forkhead members may serve as a regulatory mechanism for the tumorigenesis fostered by Wnt signaling. FoxO proteins under most conditions lead to cell cycle arrest and apoptosis. Loss of forkhead activity has been associated with tumor progression in breast, prostate and hematopoietic tissues, suggesting that FoxO proteins may be highly suitable for the control of tumor growth.
However, additional studies involving both basic and clinical work are necessary to fully comprehend the complex biological roles of Wnt signaling and forkhead transcription factors. Wnt and FoxO proteins are expressed in the central nervous system in regions that control memory and cognitive awareness but it is unclear to what degree Wnt signaling and FoxO transcription factors can influence processes of neuronal plasticity, vascular growth and immune cell activity that may relate to dementias and neuropsychiatric disorders. Further work is required to clarify both independent and shared signal transduction pathways of Wnt and FoxO proteins in order to further understand the cellular processes that can influence gene transcription and intracellular trafficking of these pathways. For example, FoxO protein transcriptional activity may sometimes assist with the treatment of neoplastic growth but the involvement of FoxO proteins during chemotherapeutic drug resistance is not entirely clear and may rely upon currently unknown parameters. These can include the modulation of FoxO post-translational activity, interaction among various FoxO members, and induction of pathways that may not be pro-apoptotic. Prediction of biological outcome during Wnt signaling or FoxO protein involvement can be difficult and may be dependent upon a host of factors such as tissue specificity, age of the organism and metabolic state, advocating a much wider investigation of Wnt and Fox signaling during both normal physiology and in disease states. Through such investigations, new therapeutic endeavors can be specifically targeted at a particular disease entity to enhance treatment efficacy and, at the same time, eliminate or minimize complications of care. A representative schematic for the pathways is shown. The canonical Wnt signaling pathway is referred to as the Wnt/β-catenin pathway since it can regulate β-catenin. All Wnt signaling pathways are initiated by interaction of Wnt proteins with Frizzled (FZD) receptors. Once Wnt protein binds to the FZD receptor and the co-receptor low-density lipoprotein receptor-related protein (LRP)-5/6, this is followed by recruitment of Dishevelled. Dishevelled can inhibit glycogen synthase kinase (GSK-3β) activity. The non-canonical or calcium Wnt signaling pathway has two intracellular signaling cascades that consist of the Wnt/Ca 2+ pathway and the Wnt/planar cell polarity (PCP) pathway. In the Wnt/Ca 2+ pathway, Wnt protein binds to FZD receptors on the cell surface resulting in several cellular processes that can involve stimulation of heterotrimeric G proteins and increased intracellular Ca 2+ release. Yet, the distinction between these pathways is sometimes not distinct and may involve non-canonical pathways, such as Wnt5a, that antagonize canonical pathways by leading to the degradation of β-catenin. Lef: Lymphoid enhancer-binding factor; Tcf: T cell factor. During stimuli such as oxidative stress, FoxO can be linked to a number of pathways that directly modulate FoxO activity, such as protein kinase B (Akt), the IκB kinase (IKK) pathway, and NF-κB, or that require FoxO to ultimately determine several cellular processes such as cell cycle regulation, apoptosis, immune system modulation, and malignancy. 
